PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Pharma
Europe: Of Apes and Ombudsmen
Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent.
This column has frequently drawn attention to the complexities of getting anything done in Europe. A brilliant researcher can explore visionary horizons, an ambitious entrepreneur can offer a package of goods or services of inestimable value, but the degree of control and regulation becomes more intense [...]
Posted in Europe, Global, Regulatory Also tagged animal research, animal rights activism, European Commission, European Ombudsman, European Union Leave a comment
Pharma and Haiti: Can Altruism Backfire?
Guest blog by Pharm Exec Europe’s Jacky Law.
Pharma companies are responding swiftly to the recent earthquake in Haiti with millions of dollars in cash and drugs. GlaxoSmithKline boasted, for example, that its initial $1.2 million offering of medicines — mainly oral and topical antibiotics — was on the first airlift to the Caribbean island and [...]
Posted in Corporate Responsibility, Global, Guest Blog, News Also tagged Big Pharma, corporate social responsibility, donations, Haiti, Johnson & Johnson Leave a comment
Connect with a Click of the Mouse
Thanks to Google, Facebook, and Twitter, the Internet has become the e-Patient’s No. 1 destination for seeking health information, and industry was all “a tweet” about it at this year’s e-Patient Connections Conference.
More than 250 people were in attendance for the two-day event, which included pharma marketers, brand managers, and patient education specialists who shared [...]
Posted in E-Media, Events Also tagged e-Patient Connections Conference, Facebook, Google, Health care, Marketing, Marketing strategy, Online Communities, Social network, Twitter Leave a comment
Europe: Go Easy on Your Pharma Lobbyists
European pharmaceutical executives are sometimes heard to complain that their public affairs departments are not doing a good job for them, and that their industry associations are a waste of time and money.
A report published in Brussels earlier this month suggests that this judgment may be excessively harsh. Lobbyists for healthcare and pharmaceuticals score [...]
Posted in Europe, Regulatory Also tagged European Union, healthcare, lobbyists, regulation Leave a comment
Nothing is Rotten in the State of Denmark